Barclays PLC Soleno Therapeutics Inc Transaction History

Barclays PLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$0.41 - $0.91 $2,797 - $6,208	-6,822 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$0.8 - $1.12 $189 - $265	237 Added 3.6%	6,822 $6,000
Q2 2021 Aug 13, 2021	SELL	$0.97 - $1.32 $41,922 - $57,049	-43,219 Reduced 86.78%	6,585 $8,000
Q1 2021 May 13, 2021	BUY	$1.24 - $3.3 $37,914 - $100,900	30,576 Added 159.02%	49,804 $63,000
Q4 2020 Feb 11, 2021	SELL	$1.61 - $2.23 $12,722 - $17,621	-7,902 Reduced 29.13%	19,228 $37,000
Q3 2020 Nov 12, 2020	BUY	$1.71 - $2.51 $15,135 - $22,216	8,851 Added 48.42%	27,130 $68,000
Q2 2020 Aug 12, 2020	BUY	$1.77 - $4.23 $32,353 - $77,320	18,279 New	18,279 $40,000

Ticker SLNO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,101,250
Market Cap $375M
Description
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.